| 1. Meng Zhang#, Qing Cong#, Xiao-Yan Zhang*, Ming-Xing Zhang, Ying-Ying Lu, Cong-Jian Xu*. Pyruvate dehydrogenase kinase 1 contributes to cisplatin resistance of ovarian cancer through EGFR activation. J Cell Physiol, 2018 Sep 19. doi: 10.1002/jcp.27369 (IF:3.923) 2. Shan-Shan Hong#, Ming-Xing Zhang#, Meng Zhang, Yi Yu, Jun Chen, Xiao-Yan Zhang*, Cong-Jian Xu*. Follicle-stimulating hormone peptide-conjugated nanoparticles for targeted shRNA delivery lead to effective gro-α silencing and antitumor activity against ovarian cancer. Drug Delivery, 2018, 25(1):576-584 (IF:3.095) 3. Mengyu Zhang#, Mingxing Zhang, Jing Wang, Qingqing Cai, Ran Zhao, Yi Yu, Haiyan Tai, Xiaoyan Zhang*, Congjian Xu*. Retro-inverso follicle-stimulating hormone peptide-mediated polyethylenimine complexes for targeted ovarian cancer gene therapy. Drug Delivery, 2018, 25(1):995-1003 (IF:3.095) 4. Ming-Xing Zhang#, Shan-Shan Hong#, Qing-Qing Cai, Meng Zhang, Jun Chen, Xiao-Yan Zhang*, Cong-Jian Xu*. Transcriptional control of the MUC16 promoter facilitates follicle-stimulating hormone peptide-conjugated shRNA nanoparticle-mediated inhibition of ovarian carcinoma in vivo. Drug Delivery, 2018, 25(1):797-806 (IF:3.095) 5. Xiao-Yan Zhang#, Meng Zhang#, Qing Cong, Ming-Xing Zhang, Meng-Yu Zhang, Ying-Ying Lu, Cong-Jian Xu*. Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy. International Journal of Biochemistry and Cell Biology, 2018, 95: 9-16 (IF:3.247) 6. Xiao-Yan Zhang#*, Shan-Shan Hong#, Meng Zhang, Qing-Qing Cai, Ming-Xing Zhang, Cong-Jian Xu*. Proteomic alterations of fibroblasts induced by ovarian cancer cells reveal potential cancer targets. Neoplasma, 2018, 65(1): 104-112 (IF:1.696) 7. Xiaoyan Zhang#, Shanshan Hong, Yu Kang, Yufang Zheng, Hong Sun, Congjian Xu*. Expression and purification of the extracellular domain of the human follicle-stimulating hormone receptor using Escherichia coli. Journal of Obstetrics and Gynaecology Research, 2014, 40(2): 501-508 (IF:1.091) 8. Jie XX#, Zhang XY*, Xu CJ*. Epithelial-to-mesenchymal transition, circulating tumor cells and cancer metastasis: Mechanisms and clinical applications. Oncotarget, 2017, 8(46):81558-81571 (Review) (IF:5.168)
近五年获得专利情况 一种经阴道取物钳(授权) (专利号)ZL201520836729.2 (申请人)尧良清,张晓燕,陈默,吴志勇,袁蕾,唐浩莎 一种经阴道肿瘤活检针 (授权) (专利号)ZL201520836580.8 (申请人)尧良清,张晓燕,陈默,吴志勇,袁蕾,唐浩莎 具有卵巢肿瘤靶向D构型多肽及其基因递释系统(申请) (专利号)CN201610849393.2 (申请人) 徐丛剑,张晓燕,张梦宇,张明星,蔡青青,尧良清 一种启动子 (申请) (专利号)CN201610849689.4 (申请人)徐丛剑,张晓燕,蔡青青,洪珊珊,张明星,尧良清 卵泡刺激素多肽修饰并由MUC16启动子调控的靶向递药系统及制备方法 (申请) (专利号)CN201610858311.0 (申请人)徐丛剑,张晓燕,张明星,洪珊珊,张梦宇,张萌 |